Circulating estrogens and progesterone during primiparous pregnancies and risk of maternal breast cancer

International Journal of Cancer

Volumn 130, Issue 4, 2012, Pages 910-920

  Lukanova, Annekatrin ^a,b   Surcel, Helja Marja ^c   Lundin, Eva ^d   Kaasila, Marjo ^c   Lakso, Hans Ake ^d   Schock, Helena ^a   Husing, Anika ^a   Kaaks, Rudolf ^a   Koskela, Pentti ^c   Grankvist, Kjell ^d   Pukkala, Eero ^e,f   Zeleniuch Jacquotte, Anne ^b,g   Lehtinen, Matti ^f   Toniolo, Paolo ^b,g,h  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d UMEÅ UNIVERSITY   (Sweden)

^e Institute for Statistical and Epidemiological Cancer Research   (Finland)

^f TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

breast cancer; estrogens; nested case control study; pregnancy; progesterone

Indexed keywords

ESTRADIOL; ESTROGEN; ESTRONE; PROGESTERONE; SEX HORMONE BINDING PROTEIN;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTRONE BLOOD LEVEL; FEMALE; FINLAND; FIRST TRIMESTER PREGNANCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; PREGNANT WOMAN; PRIMIPARA; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; TANDEM MASS SPECTROMETRY;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGENS; FEMALE; HUMANS; LOGISTIC MODELS; PREGNANCY; PROGESTERONE; RECEPTORS, ESTROGEN; RISK;

EID: 83955164294     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26070     Document Type: Article

References (38)

1. Britt K, Ashworth A, Smalley M,. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007; 14: 907-33. (Pubitemid 351252427)
2. Medina D,. Mammary developmental fate and breast cancer risk. Endocr Relat Cancer 2005; 12: 483-95. (Pubitemid 41482989)
3. Sivaraman L, Medina D,. Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 2002; 7: 77-92. (Pubitemid 38420783)
4. Ewertz M, Duffy SW, Adami HO, Kvale G, Lund E, Meirik O, Mellemgaard A, Soini I, Tulinius H,. Age at first birth, parity and risk of breast cancer: a meta-analysis of 8 studies from the Nordic countries. Int J Cancer 1990; 46: 597-603. (Pubitemid 20355746)
5. Albrektsen G, Heuch I, Hansen S, Kvale G,. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 2005; 92: 167-175. (Pubitemid 40188451)
6. Liu Q, Wuu J, Lambe M, Hsieh SF, Ekbom A, Hsieh CC,. Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control 2002; 13: 299-305. (Pubitemid 34553510)
7. Kelsey JL, Gammon MD, John EM,. Reproductive factors and breast cancer. Epidemiol Rev 1993; 15: 36-47. (Pubitemid 23269069)
8. Beral V, Reeves G,. Childbearing, oral contraceptive use, and breast cancer. Lancet 1993; 341: 1102. (Pubitemid 23114448)
9. Pathak DR, Osuch JR, He J,. Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer 2000; 88 (5 Suppl): 1230-8. (Pubitemid 30129737)
10. Clavel-Chapelon F, Gerber M,. Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? Breast Cancer Res Treat 2002; 72: 107-15. (Pubitemid 34407205)
11. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 2010; 103:250-63.
12. Ma H, Bernstein L, Pike MC, Ursin G,. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006; 8: R43.
13. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE,. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 2002; 11: 361-8. (Pubitemid 34408215)
14. Lehtinen M, Koskela P, Ogmundsdottir HM, Bloigu A, Dillner J, Gudnadottir M, Hakulinen T, Kjartansdottir A, Kvarnung M, Pukkala E, Tulinius H, Lehtinen T,. Maternal herpesvirus infections and risk of acute lymphoblastic leukemia in the offspring. Am J Epidemiol 2003; 158: 207-13. (Pubitemid 36944413)
15. Whitehead A, Whitehead J,. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991; 10: 1665-77.
16. Cleveland WS, Loader C,. Smoothing by local regression: principles and methods. In:, Schimek MG, ed. Statistical theory and computational aspects of smoothing. New York: Springer, 1996. 113-20.
17. Kleinberg DL, Wood TL, Furth PA, Lee AV,. Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions. Endocr Rev 2009; 30: 51-74.
18. Shyamala G,. Roles of estrogen and progesterone in normal mammary gland development insights from progesterone receptor null mutant mice and in situ localization of receptor. Trends Endocrinol Metab 1997; 8: 34-9. (Pubitemid 27093538)
19. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, Visvader JE,. Control of mammary stem cell function by steroid hormone signalling. Nature 2010; 465: 798-802
20. Anderson WF, Chen BE, Brinton LA, Devesa SS,. Qualitative age interactions or effect modification suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 2007; 18: 1187-98. (Pubitemid 47498167)
21. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A,. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor statusâa meta-analysis. Int J Cancer 2009; 124: 698-712.
22. Dunnwald LK, Rossing MA, Li CI,. Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 2007; 9: R6.
23. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, Smith LV, Labbok MH, Geradts J, Bensen JT, Jackson S, Nyante S, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008; 109: 123-39. (Pubitemid 351538762)
24. Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, Magnusson C,. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 2482-8. (Pubitemid 46048309)
25. Sivaraman L, Hilsenbeck SG, Zhong L, Gay J, Conneely OM, Medina D, O'Malley BW,. Early exposure of the rat mammary gland to estrogen and progesterone blocks co-localization of estrogen receptor expression and proliferation. J Endocrinol 2001; 171: 75-83. (Pubitemid 32975921)
26. Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, Kuperwasser C,. Systemic stromal effects of estrogen promote the growth of estrogen receptor-negative cancers. Cancer Res 2007; 67: 2062-71. (Pubitemid 46424224)
27. Anderson WF, Matsuno R,. Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 2006; 98: 948-51. (Pubitemid 44288160)
28. Zeleniuch-Jacquotte A, Toniolo P, Levitz M, Shore RE, Koenig KL, Banerjee S, Strax P, Pasternack BS,. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Cancer Epidemiol Biomarkers Prev 1995; 4: 857-60.
29. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, Morris HA, Tilley WD, Giles GG,. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 2010; 19: 492-502.
30. Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE,. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 2004; 96: 1856-65. (Pubitemid 40081323)
31. Sieri S, Krogh V, Bolelli G, Abagnato CA, Grioni S, Pala V, Evangelista A, Allemani C, Micheli A, Tagliabue G, Schunemann HJ, Menard S, et al. Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009; 18: 169-76.
32. Jernstrom H, Johannsson O, Borg A, Olsson H,. Do BRCA1 mutations affect the ability to breast-feed? Significantly shorter length of breast-feeding among BRCA1 mutation carriers compared with their unaffected relatives. The Breast 1998; 7: 320-4. (Pubitemid 29060398)
33. Russo J, Lynch H, Russo IH,. Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer. Breast J 2001; 7: 278-91. (Pubitemid 33101632)
34. Albrektsen G, Heuch I, Thoresen S, Kvale G,. Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer 2006; 119: 1468-74. (Pubitemid 44258827)
35. Bernstein L, Depue RH, Ross RK, Judd HL, Pike MC, Henderson BE,. Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst 1986; 76: 1035-9. (Pubitemid 16093135)
36. Arslan AA, Zeleniuch-Jacquotte A, Lukanova A, Afanasyeva Y, Katz J, Levitz M, Del PG, Toniolo P,. Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2123-30. (Pubitemid 44877035)
37. Holl K, Lundin E, Kaasila M, Grankvist K, Afanasyeva Y, Hallmans G, Lehtinen M, Pukkala E, Surcel HM, Toniolo P, Zeleniuch-Jacquotte A, Koskela P, et al. Effect of long-term storage on hormone measurements in samples from pregnant women: the experience of the finnish maternity cohort. Acta Oncol 2008; 47: 406-12. (Pubitemid 351414927)
38. Tuma R,. Mimicking pregnancy to reduce breast cancer risk. J Natl Cancer Inst 2010; 102: 517-8.